After Uzbekistan Health Ministry alleged Indian company Marion Biotech cough syrup responsible for the death of 18 children, a joint inspection of the NOIDA facility of the manufacturer, Marion Biotech, was carried out by UP Drug Control and CDSCO team.
The Central Drugs Standard Control Organisation (CDSCO) is in regular contact with the national drug regulator of Uzbekistan regarding the matter.
“Immediately on receipt of the information, joint inspection of the NOIDA facility of the manufacturer, Marion Biotech, was carried out by UP Drug Control and CDSCO team and further action as appropriate would be initiated based on the inspection report”, said union health ministry on Thursday.
The samples of the cough syrup have been taken from the manufacturing premises and sent to Regional Drugs Testing Laboratory (RDTL), Chandigarh for testing. Meanwhile, Marion Biotech Pharma company has said that it has sent samples of the said cough syrup for testing and has also halted the production of the product. Marion Biotech is a licensed manufacturer and holds license for manufacturing of Dok1 Max syrup and Tablet for export purpose granted by Drugs Controller, Uttar Pradesh.
In a rare achievement, Safdarjung Hospital has removed the world's largest ever adrenal tumour measuring…
In a landmark study that could transform osteoporosis management, researchers from the All India Institute…
The centre on Wednesday said indigenously developed HPV diagnostic kits for screening of cervical cancer…
Union health minister JP Nadda on Thursday launched the National Zero Measles-Rubella Elimination campaign 2025-26…
Underscoring that cervical cancer is the second most common after breast cancer, Dr Neerja Bhatla,…
Amid a rising trend in liver and lifestyle diseases, Prime Minister Narendra Modi on Saturday…
![](data:image/svg+xml;charset=utf-8,<svg height="32px" width="32px" xmlns="http://www.w3.org/2000/svg" version="1.1"/>)
